|
Volumn 89, Issue 5, 2016, Pages 971-973
|
Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: No longer a moving target?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANEMIC AGENT;
HEMOGLOBIN;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PLACEBO;
RECOMBINANT ERYTHROPOIETIN;
ERYTHROPOIETIN;
ANEMIA;
ARTICLE;
CHRONIC KIDNEY DISEASE;
DRUG MEGADOSE;
END STAGE RENAL DISEASE;
FATIGUE;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
KIDNEY DISEASE QUESTIONNAIRE;
LOW DRUG DOSE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
QUALITY OF LIFE ASSESSMENT;
SHORT FORM 36;
RENAL INSUFFICIENCY, CHRONIC;
RENAL REPLACEMENT THERAPY;
ANEMIA;
ERYTHROPOIETIN;
HEMATINICS;
HEMOGLOBINS;
HUMANS;
QUALITY OF LIFE;
RENAL DIALYSIS;
RENAL INSUFFICIENCY, CHRONIC;
|
EID: 84964664184
PISSN: 00852538
EISSN: 15231755
Source Type: Journal
DOI: 10.1016/j.kint.2016.03.001 Document Type: Note |
Times cited : (6)
|
References (6)
|